Clinical Trial Update: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia [Phase 3]

View source ↗

Summary

Phase 3 randomized, embedded, multifactorial adaptive platform trial evaluating treatments for community-acquired pneumonia, influenza, and COVID-19; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Snippet

Sponsor: UMC Utrecht | Conditions: Community-acquired Pneumonia, Influenza, COVID-19 | Phase 3 | Status: RECRUITING